• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications.急性肾损伤和肾脏修复中的表观遗传调控:机制和治疗意义。
Nat Rev Nephrol. 2019 Apr;15(4):220-239. doi: 10.1038/s41581-018-0103-6.
2
Epigenetic targeting for acute kidney injury.急性肾损伤的表观遗传学靶向治疗
Nephrology (Carlton). 2018 Oct;23 Suppl 4:21-25. doi: 10.1111/nep.13466.
3
Complex Pathophysiology of Acute Kidney Injury (AKI) in Aging: Epigenetic Regulation, Matrix Remodeling, and the Healing Effects of HS.衰老相关急性肾损伤(AKI)的复杂病理生理学:表观遗传调控、基质重塑和 HS 的修复作用。
Biomolecules. 2024 Sep 17;14(9):1165. doi: 10.3390/biom14091165.
4
The Role of Histone H3 Methylation in Acute Kidney Injury.组蛋白 H3 甲基化在急性肾损伤中的作用。
Drug Des Devel Ther. 2022 Aug 2;16:2453-2461. doi: 10.2147/DDDT.S376673. eCollection 2022.
5
Epigenetics in acute kidney injury.急性肾损伤中的表观遗传学
Curr Opin Nephrol Hypertens. 2015 Jul;24(4):351-8. doi: 10.1097/MNH.0000000000000140.
6
Non-coding RNAs in kidney injury and repair.非编码 RNA 在肾损伤与修复中的作用
Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C177-C188. doi: 10.1152/ajpcell.00048.2019. Epub 2019 Apr 10.
7
Epigenetic Modification Drives Acute Kidney Injury-to-Chronic Kidney Disease Progression.表观遗传修饰驱动急性肾损伤向慢性肾脏病进展。
Nephron. 2021;145(6):737-747. doi: 10.1159/000517073. Epub 2021 Aug 20.
8
Epigenetic regulation in acute kidney injury: new light in a dark area.急性肾损伤中的表观遗传调控:黑暗领域中的新曙光。
Kidney Int. 2015 Oct;88(4):665-8. doi: 10.1038/ki.2015.229.
9
Epigenetic alterations in acute kidney injury.急性肾损伤中的表观遗传学改变。
Semin Nephrol. 2013 Jul;33(4):327-40. doi: 10.1016/j.semnephrol.2013.05.005.
10
Targeting epigenetic DNA and histone modifications to treat kidney disease.靶向表观遗传 DNA 和组蛋白修饰治疗肾脏疾病。
Nephrol Dial Transplant. 2018 Nov 1;33(11):1875-1886. doi: 10.1093/ndt/gfy009.

引用本文的文献

1
The role of N6-methyladenosine (mA) RNA methylation modification in kidney diseases: from mechanism to therapeutic potential.N6-甲基腺苷(m⁶A)RNA甲基化修饰在肾脏疾病中的作用:从机制到治疗潜力
PeerJ. 2025 Aug 27;13:e19940. doi: 10.7717/peerj.19940. eCollection 2025.
2
Epigenetic memories induced by hypoxia in AKI-to-CKD transition.急性肾损伤向慢性肾病转变过程中由缺氧诱导的表观遗传记忆。
Clin Exp Nephrol. 2025 Aug 20. doi: 10.1007/s10157-025-02745-1.
3
Lysine Methyltransferases SMYD2 and SMYD3: Emerging Targets in Kidney Diseases.赖氨酸甲基转移酶SMYD2和SMYD3:肾脏疾病中的新兴靶点
Kidney Dis (Basel). 2025 Jul 1;11(1):518-529. doi: 10.1159/000547202. eCollection 2025 Jan-Dec.
4
Molecular frontiers in hemodialysis: unraveling the role of membranes in gene expression, epigenetics, and inflammatory pathways.血液透析的分子前沿:揭示膜在基因表达、表观遗传学和炎症途径中的作用
Int Urol Nephrol. 2025 Jun 25. doi: 10.1007/s11255-025-04613-z.
5
Acute kidney injury through a metabolic lens: pathological reprogramming mechanisms and clinical translation potential.从代谢角度看急性肾损伤:病理重编程机制及临床转化潜力
Front Physiol. 2025 Jun 6;16:1602865. doi: 10.3389/fphys.2025.1602865. eCollection 2025.
6
SIRT3 regulates CPT1a acetylation and fatty acid oxidation in renal tubular epithelial cells under diabetic condition.在糖尿病状态下,SIRT3调节肾小管上皮细胞中CPT1a的乙酰化和脂肪酸氧化。
Mol Biol Rep. 2025 Jun 16;52(1):603. doi: 10.1007/s11033-025-10712-y.
7
Inhibitors of p53 Apoptosis-Stimulating Protein Mitigate Acute Kidney Injury by Modulating the HIF-1α/SLC7A11 Pathway to Suppress Ferroptosis.p53凋亡刺激蛋白抑制剂通过调节HIF-1α/SLC7A11通路抑制铁死亡来减轻急性肾损伤。
J Cell Mol Med. 2025 Jun;29(11):e70580. doi: 10.1111/jcmm.70580.
8
Apoptosis Inhibitor of Macrophages in Cats: A Potential Link Between an Exon 3 Variant Allele and Progression of Naturally Occurring Chronic Kidney Disease.猫巨噬细胞凋亡抑制剂:外显子3变异等位基因与自然发生的慢性肾病进展之间的潜在联系
J Vet Intern Med. 2025 Jul-Aug;39(4):e70136. doi: 10.1111/jvim.70136.
9
Extracellular Vesicles in Acute Kidney Injury: Mechanisms, Biomarkers, and Therapeutic Potential.急性肾损伤中的细胞外囊泡:作用机制、生物标志物及治疗潜力
Int J Nanomedicine. 2025 May 17;20:6271-6288. doi: 10.2147/IJN.S519345. eCollection 2025.
10
Integration of DNA Methylome and Transcriptome Analysis to Identify Novel Epigenetic Targets in the Acute Kidney Injury-Chronic Kidney Disease Transition.整合DNA甲基化组和转录组分析以鉴定急性肾损伤-慢性肾病转化中的新型表观遗传靶点。
Biomolecules. 2025 Mar 29;15(4):498. doi: 10.3390/biom15040498.

本文引用的文献

1
High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis.高保真 CRISPR/Cas9 基因特异性羟甲基化挽救基因表达并减弱肾纤维化。
Nat Commun. 2018 Aug 29;9(1):3509. doi: 10.1038/s41467-018-05766-5.
2
LncRNA HOX transcript antisense RNA accelerated kidney injury induced by urine-derived sepsis through the miR-22/high mobility group box 1 pathway.长链非编码 RNA HOX 转录反义 RNA 通过 miR-22/高迁移率族蛋白 1 途径加速尿源性脓毒症引起的肾损伤。
Life Sci. 2018 Oct 1;210:185-191. doi: 10.1016/j.lfs.2018.08.041. Epub 2018 Aug 18.
3
Inhibition of maternally expressed gene 3 attenuated lipopolysaccharide-induced apoptosis through sponging miR-21 in renal tubular epithelial cells.母源性表达基因 3 的抑制通过海绵吸附 miR-21 减轻脂多糖诱导的肾小管上皮细胞凋亡。
J Cell Biochem. 2018 Sep;119(9):7800-7806. doi: 10.1002/jcb.27163. Epub 2018 Jun 20.
4
The Role of MicroRNAs in Kidney Disease.微小RNA在肾脏疾病中的作用。
Noncoding RNA. 2015 Nov 18;1(3):192-221. doi: 10.3390/ncrna1030192.
5
Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis.靶向组蛋白甲基转移酶zeste同源物2增强子可抑制肾上皮-间充质转化并减轻肾纤维化。
FASEB J. 2018 May 18;32(11):fj201800237R. doi: 10.1096/fj.201800237R.
6
RETRACTED: Long non-coding RNA NEAT1 plays an important role in sepsis-induced acute kidney injury by targeting miR-204 and modulating the NF-κB pathway.撤稿:长链非编码 RNA NEAT1 通过靶向 miR-204 并调节 NF-κB 通路在脓毒症诱导的急性肾损伤中发挥重要作用。
Int Immunopharmacol. 2018 Jun;59:252-260. doi: 10.1016/j.intimp.2018.03.023. Epub 2018 Apr 15.
7
Targeting epigenetic DNA and histone modifications to treat kidney disease.靶向表观遗传 DNA 和组蛋白修饰治疗肾脏疾病。
Nephrol Dial Transplant. 2018 Nov 1;33(11):1875-1886. doi: 10.1093/ndt/gfy009.
8
Genome-wide analysis revealed that DZNep reduces tubulointerstitial fibrosis via down-regulation of pro-fibrotic genes.全基因组分析显示,DZNep 通过下调致纤维化基因来减少肾小管间质纤维化。
Sci Rep. 2018 Feb 28;8(1):3779. doi: 10.1038/s41598-018-22180-5.
9
Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells.组蛋白去乙酰化酶抑制剂通过激活近端肾小管细胞自噬来预防顺铂诱导的急性肾损伤。
Cell Death Dis. 2018 Feb 23;9(3):322. doi: 10.1038/s41419-018-0374-7.
10
Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury.缺氧诱导的长链非编码 RNA Malat1 对于肾缺血/再灌注损伤不是必需的。
Sci Rep. 2018 Feb 21;8(1):3438. doi: 10.1038/s41598-018-21720-3.

急性肾损伤和肾脏修复中的表观遗传调控:机制和治疗意义。

Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications.

机构信息

Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University and Charlie Norwood VA Medical Center, Augusta, GA, USA.

Division of Nephrology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatrics Institute, Guangzhou, China.

出版信息

Nat Rev Nephrol. 2019 Apr;15(4):220-239. doi: 10.1038/s41581-018-0103-6.

DOI:10.1038/s41581-018-0103-6
PMID:30651611
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7866490/
Abstract

Acute kidney injury (AKI) is a major public health concern associated with high morbidity and mortality. Despite decades of research, the pathogenesis of AKI remains incompletely understood and effective therapies are lacking. An increasing body of evidence suggests a role for epigenetic regulation in the process of AKI and kidney repair, involving remarkable changes in histone modifications, DNA methylation and the expression of various non-coding RNAs. For instance, increases in levels of histone acetylation seem to protect kidneys from AKI and promote kidney repair. AKI is also associated with changes in genome-wide and gene-specific DNA methylation; however, the role and regulation of DNA methylation in kidney injury and repair remains largely elusive. MicroRNAs have been studied quite extensively in AKI, and a plethora of specific microRNAs have been implicated in the pathogenesis of AKI. Emerging research suggests potential for microRNAs as novel diagnostic biomarkers of AKI. Further investigation into these epigenetic mechanisms will not only generate novel insights into the mechanisms of AKI and kidney repair but also might lead to new strategies for the diagnosis and therapy of this disease.

摘要

急性肾损伤(AKI)是一个主要的公共卫生关注点,与高发病率和死亡率相关。尽管已经进行了数十年的研究,但 AKI 的发病机制仍不完全清楚,且缺乏有效的治疗方法。越来越多的证据表明,表观遗传调控在 AKI 和肾脏修复过程中起作用,涉及组蛋白修饰、DNA 甲基化和各种非编码 RNA 的表达的显著变化。例如,组蛋白乙酰化水平的增加似乎可以保护肾脏免受 AKI 的侵害并促进肾脏修复。AKI 还与全基因组和基因特异性 DNA 甲基化的变化相关;然而,DNA 甲基化在肾脏损伤和修复中的作用和调控仍在很大程度上难以捉摸。microRNAs 在 AKI 中已经得到了相当广泛的研究,并且大量特定的 microRNAs 被认为与 AKI 的发病机制有关。新兴的研究表明,microRNAs 可能成为 AKI 的新型诊断生物标志物。对这些表观遗传机制的进一步研究不仅将深入了解 AKI 和肾脏修复的机制,还可能为该疾病的诊断和治疗提供新策略。